Tayo-M – Tablets – 10’s 

Description

Tayo-M – Tablets – 10’s 

6. Pharmacokinetic Advantages

• Pyridoxal Phosphate: Bioactive form (no liver conversion needed)

• Methylcobalamin: Superior CNS penetration vs cyanocobalamin

• Calcium Carbonate: Best absorbed with food (acidic environment)

7. Safety Profile

• Common: Mild GI upset (take with meals to minimize)

• Serious (Rare):

  • Hypercalcemia (monitor if >1000mg Ca++ daily from all sources)

  • B6-induced peripheral neuropathy (only at doses >50mg/day long-term)

8. Critical Interactions

• Reduced Absorption:

  • Calcium ↓ fluoroquinolone/thyroxine absorption (separate by 4hrs)

• Enhanced Effects:

  • B12 + Metformin (may require dose adjustment)

9. Special Populations

• Pregnancy: Safe (Folic acid prevents NTDs)

• Renal Impairment: Caution with calcium (monitor serum levels)

• Bariatric Patients: Ideal formulation (pre-digested B-vitamins)

10. Market Positioning

• Unique Selling Proposition: Only Indian formulation combining:

  • Osteoporosis care +

  • Neuropathy management +

  • Cardiovascular protection

11. Storage

• Conditions: Below 30°C

• Stability: 24 months from manufacture

12. Manufacturer Insights

Likely produced by:

• Eris Lifesciences (known for neuro-nutraceuticals) or

• Mankind Pharma (strong bone health portfolio)

Prescription Status: Schedule H drug in India